CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$3,410,000
+3.0%
28,796
+2.8%
0.00%0.0%
Q4 2020$3,310,000
+9.7%
28,023
+3.2%
0.00%0.0%
Q3 2020$3,018,000
+5.5%
27,153
-3.0%
0.00%0.0%
Q2 2020$2,862,000
-16.9%
28,005
-12.2%
0.00%
-50.0%
Q1 2020$3,442,000
-12.2%
31,882
-5.4%
0.00%0.0%
Q4 2019$3,922,000
+4.2%
33,694
+2.5%
0.00%0.0%
Q3 2019$3,764,00032,8800.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2021
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders